miR-215-5p in exosomes may exert protective effects against the development of AD by targeting BCL2L11. In this study, a training group of more than 400 cases and a test group of more than 200 cases were obtained using two different datasets, thus, potentially making the results of this study highly reliable. This evidence concerns the gene BCL2L11 and Alzheimer disease.